US$ 26.71
insurance dropping glp 1 UVM Health cutting GLP-1 weight-loss drug coverage for employees What Is Insurance Prior Authorization
Description
Summary Ozempic is an injectable diabetes medication

In fact, studies show that GLP-1 receptor agonists may help people maintain an average weight loss of up to 17% of their initial body weight (Rubino, 2021)

Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase and clinical trials

Endocrinology (2008) 149(3):133849

In fact, although diabetes is the main cause for end-stage kidney disease (ESKD) worldwide, many people with T2D die from CVD before reaching ESKD [2]

If symptoms persist beyond the early titration period, temporary dose stabilization or dose reduction should be considered
